Supply Chain Disruptions & Solutions

The global active pharmaceutical ingredient (API) supply chain is experiencing its most disruptive year in decades. With 80% of generic APIs still sourced from China, a combination of geopolitical tensions, export restrictions, and climate-related disruptions is causing unprecedented shortages. In 2025 alone, over 300 critical APIs are flagged as high risk for severe delivery delays.…

The pharma supply chain is bracing for one of its most complex years yet. With global markets shifting under the weight of geopolitical tensions, extreme weather events, and evolving regulatory frameworks, companies are entering what many experts call a “triple threat” environment. In 2025, resilience will not just be about surviving disruptions—it will be about…